Related Experiment Video
Updated: Jul 1, 2025
08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
11.9K
[TRANSLATIONAL MEDICINE IN MALIGNANT HEMATOLOGY]
1Department of Hematology, Tel Aviv Sourasky (Ichilov) Medical Center Tel-Aviv University, Tel-Aviv.
Harefuah
|March 3, 2024
Summary
Translational medicine accelerates medical breakthroughs by applying research to patient care. This approach has notably advanced the treatment of malignant hematology.
Area of Science:
- Translational medicine
- Medical research
- Clinical application
Context:
- Bridging basic science and clinical practice
- Improving patient management
- Disease prevention, diagnosis, and treatment
Purpose:
- To highlight the role of translational medicine
- To showcase its impact on patient outcomes
- To emphasize its contribution to medical advancements
Summary:
- Translational medicine integrates research findings into clinical practice.
- It facilitates the development of novel strategies for disease management.
- Significant advancements in malignant hematology exemplify its success.
Impact:
- Enhanced patient care and management
- Accelerated development of diagnostics and therapeutics
- Improved outcomes in various diseases, particularly in malignant hematology
Related Concept Videos
01:31Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
01:22Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K